NF1 and cancer: Cancer in patients with NF1 manifests in multiple and previously unrecognized ways. The accumulation of mutations that lead to malignancy may occur earlier in patients with NF1 than in control populations, leading to the increased cancer risk of more cancer types than previously have been observed. These findings should translate to clinical practices to determine clinical interventions and focussed follow‐up of patients with NF1